IN2012DN01661A - - Google Patents
Download PDFInfo
- Publication number
- IN2012DN01661A IN2012DN01661A IN1661DEN2012A IN2012DN01661A IN 2012DN01661 A IN2012DN01661 A IN 2012DN01661A IN 1661DEN2012 A IN1661DEN2012 A IN 1661DEN2012A IN 2012DN01661 A IN2012DN01661 A IN 2012DN01661A
- Authority
- IN
- India
- Prior art keywords
- disclosed
- compounds
- intended
- kits
- abstract
- Prior art date
Links
- 150000001875 compounds Chemical class 0.000 abstract 3
- 102000011420 Phospholipase D Human genes 0.000 abstract 1
- 108090000553 Phospholipase D Proteins 0.000 abstract 1
- 102000001708 Protein Isoforms Human genes 0.000 abstract 1
- 108010029485 Protein Isoforms Proteins 0.000 abstract 1
- 239000003112 inhibitor Substances 0.000 abstract 1
- 239000008194 pharmaceutical composition Substances 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
- C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
- C07D471/10—Spiro-condensed systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/438—The ring being spiro-condensed with carbocyclic or heterocyclic ring systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Epidemiology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US22849209P | 2009-07-24 | 2009-07-24 | |
| PCT/US2010/043045 WO2011011680A1 (en) | 2009-07-24 | 2010-07-23 | Isoform selective phospholipase d inhibitors |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| IN2012DN01661A true IN2012DN01661A (pl) | 2015-06-05 |
Family
ID=43499428
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| IN1661DEN2012 IN2012DN01661A (pl) | 2009-07-24 | 2010-07-23 |
Country Status (14)
| Country | Link |
|---|---|
| US (1) | US9127005B2 (pl) |
| EP (1) | EP2456307B1 (pl) |
| JP (1) | JP2013500260A (pl) |
| KR (1) | KR20120090034A (pl) |
| CN (1) | CN102573474A (pl) |
| AU (1) | AU2010275526A1 (pl) |
| BR (1) | BR112012001586A2 (pl) |
| CA (1) | CA2768940C (pl) |
| IL (1) | IL217720A0 (pl) |
| IN (1) | IN2012DN01661A (pl) |
| MX (1) | MX2012001064A (pl) |
| RU (1) | RU2012106657A (pl) |
| SG (1) | SG178102A1 (pl) |
| WO (1) | WO2011011680A1 (pl) |
Cited By (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US9453017B2 (en) | 2011-09-30 | 2016-09-27 | Vanderbilt University | Antiviral therapies with phospholipase D inhibitors |
Families Citing this family (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| SG178102A1 (en) | 2009-07-24 | 2012-03-29 | Univ Vanderbilt | Isoform selective phospholipase d inhibitors |
| AU2013359315B2 (en) * | 2012-12-11 | 2016-12-08 | Vanderbilt University | Methods and compositions comprising Akt inhibitors and/or phospholipase D inhibitors |
| CA2894843A1 (en) * | 2012-12-11 | 2014-06-19 | Vanderbilt University | Methods and compositions of treating hiv infection |
| CN114778844A (zh) * | 2022-03-07 | 2022-07-22 | 天津市肿瘤医院（天津医科大学肿瘤医院） | Pld1作为评估肿瘤患者对于化疗药物敏感性的分子标志物的用途 |
| TW202413374A (zh) * | 2022-06-16 | 2024-04-01 | 日商日本煙草產業股份有限公司 | 二氫二𠯤酮化合物及其醫藥用途 |
Family Cites Families (17)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| IT1281502B1 (it) | 1995-06-13 | 1998-02-18 | Sardinian Antiviral Research C | Impiego di un inibitore non nucleosidico della trascrittasi inversa in associazione con inibitori nucleosidici per il trattamento della |
| US6187559B1 (en) | 1997-08-28 | 2001-02-13 | Novartis Ag | Phospholipase D gene |
| EP1313498A4 (en) | 2000-05-25 | 2004-04-21 | Ben-Tsion Williger | PHOSPHOLIPASE D EFFECTORS FOR THERAPY AND SCREENING |
| US6482829B2 (en) * | 2000-06-08 | 2002-11-19 | Hoffmann-La Roche Inc. | Substituted heterocyclic siprodecane compound active as an antagonist of neurokinin 1 receptor |
| KR101144889B1 (ko) | 2002-09-18 | 2012-05-14 | 학교법인 포항공과대학교 | 포스포리파제 ｄ를 포함하는 펩티드 복합체 |
| CN101128435A (zh) * | 2004-12-27 | 2008-02-20 | 阿斯利康(瑞典)有限公司 | 作为代谢型谷氨酸受体激动剂用于治疗神经病学及精神病学病症的吡唑酮化合物 |
| JP2008542192A (ja) | 2005-02-23 | 2008-11-27 | アービサー ジャック エル． | 増殖の障害の治療用のホノキオール誘導体 |
| MX2008014690A (es) * | 2006-05-18 | 2008-11-27 | Hoffmann La Roche | Derivados de tiazolo-pirimidina/piridina-urea. |
| US20100009970A1 (en) | 2008-03-19 | 2010-01-14 | Combinatorx (Singapore) Pte. Ltd. | Compositions and methods for treatment of viral diseases |
| WO2010037081A1 (en) | 2008-09-29 | 2010-04-01 | Palatin Technologies, Inc. | Melanocortin receptor-specific spiro-piperidine compounds |
| JP6029467B2 (ja) | 2009-03-31 | 2016-11-24 | サノフィ−アベンティス・ドイチュラント・ゲゼルシャフト・ミット・ベシュレンクテル・ハフツング | 薬物送達デバイスの本体 |
| CN102459584A (zh) | 2009-05-29 | 2012-05-16 | 纽约市哥伦比亚大学理事会 | 用于治疗神经退行性病症的磷脂酶d的调节 |
| SG178102A1 (en) | 2009-07-24 | 2012-03-29 | Univ Vanderbilt | Isoform selective phospholipase d inhibitors |
| WO2011019498A1 (en) | 2009-07-27 | 2011-02-17 | The Trustees Of Princeton University | Inhibition of glycerol-3-phosphate acyltransferase (gpat) and associated enzymes for treatment of viral infections |
| EP2760447A4 (en) | 2011-09-30 | 2015-10-21 | Univ Vanderbilt | ANTIVIRAL THERAPIES WITH D PHOSPHOLIPASE INHIBITORS |
| CA2894843A1 (en) | 2012-12-11 | 2014-06-19 | Vanderbilt University | Methods and compositions of treating hiv infection |
| AU2013359315B2 (en) | 2012-12-11 | 2016-12-08 | Vanderbilt University | Methods and compositions comprising Akt inhibitors and/or phospholipase D inhibitors |
-
2010
- 2010-07-23 SG SG2012005252A patent/SG178102A1/en unknown
- 2010-07-23 US US13/386,397 patent/US9127005B2/en not_active Expired - Fee Related
- 2010-07-23 JP JP2012521826A patent/JP2013500260A/ja active Pending
- 2010-07-23 EP EP10802947.1A patent/EP2456307B1/en not_active Not-in-force
- 2010-07-23 KR KR1020127004698A patent/KR20120090034A/ko not_active Withdrawn
- 2010-07-23 AU AU2010275526A patent/AU2010275526A1/en not_active Abandoned
- 2010-07-23 RU RU2012106657/04A patent/RU2012106657A/ru not_active Application Discontinuation
- 2010-07-23 BR BRBR112012001586-9A patent/BR112012001586A2/pt not_active IP Right Cessation
- 2010-07-23 IN IN1661DEN2012 patent/IN2012DN01661A/en unknown
- 2010-07-23 MX MX2012001064A patent/MX2012001064A/es not_active Application Discontinuation
- 2010-07-23 CN CN2010800423044A patent/CN102573474A/zh active Pending
- 2010-07-23 CA CA2768940A patent/CA2768940C/en not_active Expired - Fee Related
- 2010-07-23 WO PCT/US2010/043045 patent/WO2011011680A1/en not_active Ceased
-
2012
- 2012-01-24 IL IL217720A patent/IL217720A0/en unknown
Cited By (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US9453017B2 (en) | 2011-09-30 | 2016-09-27 | Vanderbilt University | Antiviral therapies with phospholipase D inhibitors |
Also Published As
| Publication number | Publication date |
|---|---|
| KR20120090034A (ko) | 2012-08-16 |
| US9127005B2 (en) | 2015-09-08 |
| RU2012106657A (ru) | 2013-08-27 |
| EP2456307A1 (en) | 2012-05-30 |
| EP2456307A4 (en) | 2013-01-16 |
| US20120214832A1 (en) | 2012-08-23 |
| CN102573474A (zh) | 2012-07-11 |
| JP2013500260A (ja) | 2013-01-07 |
| WO2011011680A1 (en) | 2011-01-27 |
| CA2768940C (en) | 2018-03-13 |
| SG178102A1 (en) | 2012-03-29 |
| CA2768940A1 (en) | 2011-01-27 |
| IL217720A0 (en) | 2012-03-29 |
| MX2012001064A (es) | 2012-07-17 |
| AU2010275526A1 (en) | 2012-03-15 |
| EP2456307B1 (en) | 2016-11-02 |
| BR112012001586A2 (pt) | 2015-09-01 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| MY150542A (en) | Cmet inhibitors | |
| PT2470546E (pt) | Compostos de hexa-hidrooxazinopteridina para serem utilizados como inibidores de mtor | |
| MY150596A (en) | Hsp90 inhibitors | |
| EA201190227A1 (ru) | Оксазолзамещенные индазолы в качестве ингибиторов pi3-киназ | |
| WO2010008847A3 (en) | Pi3k/m tor inhibitors | |
| TR201203989T1 (tr) | Ksantin oksidaz inhibitörleri olarak etkin olan yeni bileşikler, bunları hazırlamaya yönelik yöntem ve bunları içeren farmasötik bileşim. | |
| WO2013003298A3 (en) | Inhibitors of pde10 | |
| NZ704662A (en) | Crystalline forms of the prolyl hydroxylase inhibitor [(4-hydroxy-1-methyl-7-phenoxy-isoquinoline-3-carbonyl)-amino]-acetic acid | |
| BRPI1009333B8 (pt) | compostos inibidores de beta-secretase, seus usos, bem como composição farmacêutica | |
| MX336381B (es) | Boronatos como inhibidores de arginasa. | |
| WO2013067349A9 (en) | Novel chemistry used in biosensors | |
| MY160625A (en) | Process for preparing pan-cdk inhibitors of the formula(i), and intermediates in the preparation | |
| EA201490912A1 (ru) | Производные [1,2,3]триазоло[4,5-d]пиримидина в качестве агонистов каннабиноидного рецептора 2 | |
| ECSP12011581A (es) | Inhibidores de bace | |
| BR112013031405A2 (pt) | piridopirazinas substituídas como novos inibidores de syk | |
| UA111198C2 (uk) | Похідні 1-феніл-2-піридинілалкільних спиртів як інгібітори фосфодіестерази | |
| EA201270302A1 (ru) | Безводные формы производных пиридина | |
| JO2673B1 (en) | New diosmetin compounds, a process for their preparation and pharmaceutical compositions containing them | |
| CY1112829T1 (el) | Νεα μεθοδος συνθεσης για την αγομελατινη | |
| EA201391481A1 (ru) | Аналоги эпоксиэйкозатриеновой кислоты и способы их получения и использования | |
| MX2012007341A (es) | Inhibidores de proteasoma y procesos para su preparacion, purificacion y uso. | |
| IN2012DN01661A (pl) | ||
| EA200900090A1 (ru) | Бензиламины, способ их получения и их применение в качестве противовоспалительных средств | |
| PH12015501175A1 (en) | Substituted pyridopyrazines as syk inhibitors | |
| MX391837B (es) | Composiciones depuradoras de oxigeno. |